Both in Pharmaceuticals
Pasithea Therapeutics vs Marker Therapeutics
Over the past year KTTA returned −43.6% and MRKR returned −6.8%; their daily moves had a correlation of 0.15.
KTTA −43.6% MRKR −6.8%Growth of $1, one year, split-adjusted
| Metric | KTTA | MRKR |
|---|---|---|
| Price | $0.4049 | $0.9601 |
| Market cap | $13.5M | $16.0M |
| Today | −9.05% | −10.27% |
| 1 month | −21.2% | −19.3% |
| 6 months | −41.3% | −31.4% |
| Year to date | −68.6% | −35.6% |
| 1 year | −43.7% | −3.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 6.9× |
| Net cash | $45.7M | $11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 83.0% |
| Short % of float | 0.5% | 1.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).